This working model is consistent with the concept of the role of tumour microenvironment in the control of cells contained in a tumour.34 The treatment of ECs with SUT inhibits VE-cadherin tyrosine phosphorylation which then inhibits the cleavage and the release of sVE. Here, CDH5 is linked to neoplasm.